Could a simple drug make nose jobs safer and less bruising?
NCT ID NCT05774717
First seen May 14, 2026 · Last updated Jun 19, 2026 · Updated 7 times
Summary
This study tests whether a single dose of tranexamic acid (TXA), given just before nose surgery, can reduce bleeding during the operation and lessen bruising and swelling afterward. Sixty adults having cosmetic or functional rhinoplasty will be randomly assigned to receive TXA or a placebo. The goal is to see if this common drug can improve recovery without causing serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tranexamic acid (TXA)
What this could lead to
If it works, this could give surgeons a simple way to reduce bleeding, bruising, and swelling after nose surgery, helping patients recover more comfortably.
What could go wrong
This is a small, early-phase trial with only 60 people, so results may not apply to everyone. TXA also carries rare risks like blood clots or allergic reactions.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.